Source link : https://newshealth.biz/health-news/durvalumab-plus-bcg-earns-fda-nod-for-bladder-cancer/
The combination therapy is approved for BCG-naive patients with high-risk non-muscle-invasive disease. Medscape Medical News Source link : https://www.medscape.com/viewarticle/durvalumab-plus-bcg-earns-fda-nod-bladder-cancer-2026a1000hv5?src=rss Author : Publish date : 2026-05-28 20:20:00 Copyright for syndicated content belongs to the linked Source.
The post Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-28 20:20:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8